Background The annual health check (AHC) programme, as part of a Directed Enhanced Service, offers an incentive to general practitioners in England to conduct health checks for people with intellectual disabilities (IDs). The aim of this analysis was to estimate the impact on health care costs of AHCs in primary care to the National Health Service in England by comparing adults with ID who did or did not have AHCs using data obtained from The Health Improvement Network. Methods Two hundred eight records of people with ID from The Health Improvement Network database were analysed. Baseline health care resource use was captured at the time the first AHC was recorded (i.e. index date), or the earliest date after 1 April 2008 for those without an AHC. We examined the volume of resource use and associated costs that occurred at the time AHCs were performed, as well as before and after the index date. We then estimated the impact of AHCs on health care costs.
Introduction
An increasing proportion of the people with intellectual disability (ID) lives in the community and often has associated health issues, such as cardiovascular, respiratory, gastrointestinal, endocrine and mental health problems and epilepsy (Cooper et al. 2007; Emerson et al. 2013) . People with ID are less likely to access routine health checks, which may be a result of needing to rely on their family/carers to attend general practitioner (GP) appointments (Alborz et al. 2005) . Therefore, appropriate health care is essential for this population given the high morbidity burden, and the early intervention of their GP is therefore very important to their overall health (Emerson & Baines 2010) . In the UK, the GP is the primary health care provider of people with ID. Implementation of a management plan, compliance and continuity of care for people with ID could help in the identification of important co-morbidities, which might lead to a reduction in avoidable health issues and deaths if effectively managed.
The National Health Service (NHS) England introduced the annual health check (AHC) programme for people with ID in 2008/2009 as a Directed Enhanced Service (DES) in primary care. This enhanced service is designed to encourage GP practices to identify all patients aged 14 and over with ID, to maintain an ID 'health check' register and to offer patients AHCs, which will include producing a health action plan [The NHS Confederation (Employers) 2012]. Annual health checks for people with ID are designed to improve their health by identifying unmet needs, potentially treatable conditions and timely access to further care. The approximate number of those with ID and significant impairment in functional abilities known to service providers in England and thus eligible for AHCs was estimated to be over 214 000 in 2013/2014 (Hatton et al. 2016) .
The Royal College of General Practitioners (RCGP) produced guidelines that GPs should carry out AHCs for all people with an ID (RCGP 2010) . This recommends that all health checks include an assessment of feeding, and bowel and bladder functions; assessment of behavioural disturbance; and assessment of vision and hearing. There are also some syndrome-specific checks that GPs should carry out for people with specific conditions associated with particular physical health problems, such as in people with Down syndrome. In 2012/2013, 52% of eligible people with IDs received an AHC (Glover & Niggebrugge 2013) .
It has been shown that people with ID from general practices that had enrolled in the AHC programme were offered significantly more general health measurements, blood tests and specific health screening than were people with ID from general practices that had not enrolled in the programme, and identification rates for previously unidentified health problems were also higher (Buszewicz et al. 2014) .
Undertaking comprehensive AHCs may, however, require considerable effort in terms of resource use, which will be associated with costs within primary health care services. Health checks were estimated to cost the NHS £60.7 million over 3 years based on estimates of associated activity, costs and uptake by general practices (DoH 2009).
There is limited published literature quantifying the cost impact of AHCs in people with IDs; and, for those existing, the setting, population and methodology used make comparison across the studies difficult. A study conducted in Greater Glasgow Health Board area, Scotland, in 100 people with ID (50 of whom received an AHC) around the time of the introduction of AHCs in England suggested that there were no increased costs in terms of service use, and the study concluded that AHCs are relatively inexpensive (mean cost per person estimated at £82) and do not have significant service implications (Romeo et al. 2009) .
In addition, a study conducted in Australia (Gordon et al. 2012) showed no significant differences in health care costs over 12 months between people with ID who received health assessments and people who did not receive health assessments (AUD 4523 vs. AUD 4466). The authors concluded that health assessments led to significantly increased health promotion but overall created a neutral impact on costs, while the assessment encouraged more targeted patient services.
The aim of this analysis was to estimate the resource use and the impact on health care costs of AHCs in primary care to the NHS in England by comparing adults with ID who did or did not have AHCs using data obtained from The Health Improvement Network (THIN). This included the cost of the AHC, and it also investigating whether the AHCs generated additional costs to the NHS by identifying additional medical care needed.
Methods

Data source and study population
The Health Improvement Network research database is a longitudinal primary care database of over 12 million anonymised primary care medical records collected from 587 general practices in the UK, covering 5.7% of the UK population in 2014. THIN data are representative for the UK population (IMS Health RWES 2016) .
The Health Improvement Network database contains diagnostic and prescribing information recorded by GPs who have opted into the data recording scheme as part of their routine clinical practice, and it is used extensively for research purposes. Data are recorded using coded clinical language [Read codes (Chisholm 1990) ], which consist of a hierarchically arranged comprehensive list of clinical terms to describe the health care of patients in general practice, and encrypted identification codes from the UK Prescription Pricing Authority (Joint Formulary Committee 2013) classified according to the British National Formulary for prescriptions.
The data for this study were extracted from a larger study (Buszewicz et al. 2014) , which investigated whether the AHC programme had improved health care for people with ID using data from THIN research database. English general medical practices were included if, before 1 January 2009, the average annual recording rates were at least one medical record, one additional health data record and two prescription records per person per year across the whole practice population, and practice mortality recording rates were similar to general UK population mortality after accounting for the distributions of age and sex. Eligible persons were aged at least 18 years and had known ID identified with specific Read codes used to include them in the practice Quality and Outcomes Framework (QOF) register. The QOF is a system for the performance management and payment of GPs in the NHS 
Health care resource use
Annual health check
When identifying relevant Read codes, we used those recommended by the guideline produced to help GPs and practice nurses to organise and perform high-quality AHCs in people with ID: weight, height and blood pressure measurement; blood and urine analysis; smoking, alcohol and illegal drugs status; vision, hearing, communication and mobility assessment; immunisation/vaccination status; cervical screening and mammography status; chronic illnesses enquiry; sexual health enquiry; behavioural changes; medication review and prescriptions; proposed health action plan; and syndrome-specific medical health checks (RCGP 2010).
Primary care services
Read codes were used to estimate the number of primary health care professional contacts before and after the index date, and any other resources accessed. The mean number of primary health care contacts was calculated as the sum of all recorded contacts within primary care. Contacts with primary health care professionals were classified into the following categories: GP visits (at general practice/home or phone consultation), practice nurse visits (at general practice/home or phone consultation) and community nurse visits (at general practice or clinic/home or phone consultation).
Secondary care services
The mean number of referrals to secondary care services, laboratory and imaging and other outpatient services, and accident and emergency services were calculated. Secondary care is captured in THIN via Read codes when either patients are referred to a secondary care service or they have an unplanned contact with a secondary care service and a letter is sent to their GP. As the database does not directly capture secondary care service use (only a limited number of general practices are linked to the Hospital Episode Statistics), some of the data on secondary care services may be incomplete. Hence, we made the following assumptions to estimate secondary care services utilisation: for data recorded on THIN about any type of hospitalisation, the length of stay was calculated by subtracting the admission date from the discharge date from the information recorded within the study period. Where this information was not available, we used the mean length of stay (DoH 2015) for the condition/procedures for which people with ID were hospitalised. Outpatient appointments were accounted for if a referral to an outpatient service was not followed by an entry of 'did not attend' or if there was evidence of recording of outcomes of an outpatient contact in the GP records.
Prescriptions
All recorded prescriptions were aggregated for each person, with the number of individual doses prescribed before and after the index date. Net ingredient costs per dose, based on the September 2014 edition of the British National Formulary, were applied to the doses recorded, in order to arrive at a total cost of prescriptions issued.
Health care resource costs
Costs were estimated by multiplying the number of units used for each relevant resource factor obtained from THIN database with the corresponding unit cost (Table S1 ). Total costs were measured as average yearly costs by adding up the total primary and secondary care costs, inpatient care costs, outpatient care costs and prescription costs.
Based on providing evidence of completed AHCs, general practices receive payment under the DES on a quarterly basis calculated from the number of completed AHCs for people with ID undertaken in the previous quarter. Accordingly, we included this payment (£100 per health check at the time we conducted the study) for those who had undergone first AHC in this study [The NHS Confederation (Employers) 2012]. Where multiple AHCs following the index date AHC were recorded, we considered them as GP visits.
Resource use costs were calculated using cost references from the NHS national schedule of reference costs (DoH 2015) and the Personal Social Services Research Unit (Curtis 2014) . Costs were calculated in 2013/2014 UK pounds (£).
Statistical methods
Summaries are presented as means and standard deviations (SDs) for continuous outcomes and numbers and percentages (%) for categorical outcomes. The outcomes of interests were the mean number of different types of person-level health services resource utilisation and their associated costs before and after the index date in both (AHC and no AHC) groups. The resource utilisation and associated costs before and after the index date for each group were compared using t-tests. We considered the statistical significance to be at the 5% level.
We then examined factors associated with health care costs using negative binomial regression (Cameron & Trivedi 2013) , including the length of time before and after the index date (exposure duration) which differed between individual persons, and in particular between the AHC (mean 1.85 years) and the no AHC (mean 3.75 years) groups. The difference between the two groups was predominate because we chose the 'earliest possible time point they could have received an AHC' as the index date for the no AHC group; a problem with this is that longer periods of time would likely have been associated with higher number of resource use and that shorter periods of time would likewise be likely to have a lower number for resource use. Given that failure to account for variability in exposure duration could bias the regression results, we included exposure duration for each person in the regression analysis to account for the potential number of times the event could have happened (Atkins et al. 2013) .
The influence of AHC on each individual's health care costs was analysed using the negative binomial regression model, adjusting for age and gender, with the total health care cost after the index date as response variable; the exposure duration as the offset; and the AHC, age, gender and costs before the index date as explanatory variables. Results are presented as incident rate ratios. We would have attempted to control for severity of the ID, but a large amount of medical records (>65% in each group) did not have a clear entry for the severity of ID. Analyses were performed using STATA version 14.1 (StataCorp 2014).
Results
Demographic characteristics
The medical records of identified people with ID (n = 208; 106 with AHC and 102 with no AHC) came from 12 incentivised general practices. The number of medical records per general practice ranged from 7 to 36. The groups were fairly well balanced in terms of age and gender. Severity of ID was poorly recorded in both groups. There was an uneven geographical representation; more medical records in the no AHC group were from the South East Coast, whereas more medical records in the AHC group were from London. Demographic characteristics are presented in Table 1 .
Annual health check routine assessments
The mean number (SD) of routine assessments performed during an AHC was 8.83 (4.27), and they were conducted by either practice nurses (48% of the AHCs) or GPs (44% of the AHCs). The mean number of routine assessments per AHC was similar whether they were conducted by practice nurses (9.63; SD 4.00) or GPs (9.34; SD 3.71). There were people with ID who had more than one AHC during the study period. Weight, blood pressure measurements, alcohol status, mobility, hearing and vision assessments, and dental examinations were performed, and a health action plan was offered at more than 50% of the AHC visits. Other routine assessment included basic assessment of behaviour and communication, 'other medical' (as they were recorded) assessments, smoking status recording, weight monitoring, medication review, health education and referral for laboratory tests. There was a mean (SD) of 2.18 (2.50) prescriptions issued per AHC visit; 32% of people with ID received prescriptions for central nervous system problems, followed by 18% for cardiovascular system problems. Other prescriptions were issued for skin, respiratory system, gastrointestinal system and endocrine system problems ( Table 2) .
Health care resource use and costs
There were statistically significant increases in mean number of contacts with GPs (1.59; P = 0.033), practice nurses (0.51; P = 0.015) and community nurses (0.08; P = 0.018) in the no AHC group after the index date. Statistically significant increases in primary care resource use in the AHC group after the index date were observed in the mean number of GP phone contacts (0.46; P = 0.014) ( Table 3) . People in the no AHC group had a significant increase in the mean number of unplanned admissions (admissions with no referral letter) (0.06; P = 0.018), and contacts with community health care services (0.15; P = 0.044), as well as outpatient contacts (0.59; P = 0.002). The only statistically significant increase in the AHC group was in the mean number of outpatient contacts (1.15; P = 0.001) ( Table 3) .
The mean number of prescriptions for immune system agents (0.09; P = 0.013) increased significantly in the AHC group after the index date ( Table 3) .
To note is that for both groups the level of resource utilisation increased after the index date. Although the level of resource utilisation before the index date was lower in the no AHC group than in the AHC group, it increased after the index date, almost reaching the level of resource utilisation in the AHC group.
The average cost of an AHC was estimated at £142.57 (95%CI £135.41 to £149.74).
There was statistically significant increase in costs for primary care contacts (£96.43; P = 0.020) and community and secondary care activities (£157.79; P = 0.008) in the no AHC group after the index date (Table 4) .
Differences in total costs before and after the index date were not statistically significant in any of the groups; in the no AHC group, this difference was double that of the AHC group owing to a higher increase in resource utilisation after the index date. Even so, the total cost in the AHC group remained higher than in the no AHC group.
The results of the negative binomial regression analysis are detailed in Table 5 . Holding other regressors and the standard error constant, the expected health care cost for those who have an AHC is 56% higher than that for those who did not have an AHC. Similarly, the expected health care cost for women was 55% higher than for men. For each additional year of age, the expected health care cost is increased by 1.6%.
Discussion
This study analysed the impact of the AHC scheme specifically targeting people with ID in the community setting using THIN dataset. Based on an in-depth review of health care activity following disorders, constipation and being underweight or obese (Buszewicz et al. 2014) .
In general, resource utilisation was lower in the no AHC group than in the AHC group before the index date; however, the resource utilisation increased in both groups after the index date. To note is that the levels of resource utilisation in the no AHC group increased after the index date, almost reaching the levels of those in the AHC group. We observed a significant increase in contacts with GPs, practice nurses, and community nurses and health care services, as well as in outpatient appointments and unplanned hospital admissions for the people who did not receive an AHC. For people who did receive an AHC, there was significant increase in GP phone consultations, and outpatient appointments. Hence, we found that the burden of health care resources was higher after the index date in both groups, yet significant increases in primary/community and secondary care resources utilisation were noted predominantly in resource use associated with unplanned health care attendances in the no AHC group, whereas this same pattern was not seen in the AHC group. This suggests that AHCs may have helped to identify and manage the type of problems that might otherwise lead to unplanned health care resource use.
Our study cannot reveal why people with ID registered with an incentivised general practice did not receive an AHC. A previous study (Buszewicz et al. 2014) showed that Read codes identifying that people with ID had been invited to attend a health check were infrequently used, and most general practices only recorded completion of incentivised health checks. Our study also cannot reveal why people with ID in the no AHC group were seeking significantly more primary/community and secondary care and had more prescriptions for central nervous system after the index date, and further research on this is required. It could be that people with more complex health needs (e.g. more severe ID) are more likely to obtain more health care. However, we were unable to conclude that severity of ID potentially increased health care resource utilisation owing to the fact that the severity of people's ID was seldom recorded in our sample.
People with ID are some of the highest consumers of medications (e.g. psychotropic and anti-epileptic) with high rates of potentially serious side effects (de Kuijper et al. 2010) . Our study was unable to conclude that the higher numbers of prescriptions for cardiovascular, central nervous and gastrointestinal problems in the AHC group were driven by the severity of the people's ID or other reasons. However, the number of prescriptions in the AHC group appeared to go down slightly after the index date, as well as the associated costs, which may be due to active health promotion strategies around diet and exercise put in place during the AHCs to avoid potential significant interactions.
Although AHCs result in increased expected costs mainly owing to referrals to other services, they appeared to result in better health monitoring and more preventive care (e.g. immunisations), which may be associated with a reduction in unexpected visits and non-elective admissions, and possibly reduced mortality rate. AHCs therefore seem to be effective in reducing health inequalities as intended, although further work to determine the medium-to-long-term impact of AHCs on outcomes, their long-term costs and any financial gains from conducting AHCs is needed (Cooper et al. 2014) .
Strengths and limitations
This is the first study to explore the costs associated with health care provision to people with ID using a tool such as THIN research database. However, the results presented here are different from those reported in another UK study (Romeo et al. 2009) where the mean cost of AHCs (£82) was lower than in our study (£143). This may be because we included the general practice reimbursement of £100 per person for completed first AHC. Another explanation could be that in the former study, AHCs were performed by practice nurses, whereas in our study, we found that in 44% of the cases, AHCs were performed by GPs who were costed at a higher rate than were practice nurses in our analysis.
One limitation could be that the sample size was too small, and ,therefore this study is possibly underpowered to detect differences in health care costs between the AHC and no AHC groups. We conducted a number of statistical tests of changes in health care use before and after the index date, and hence, some of the significant findings may be by chance. However, although the sample size was small, the longitudinal nature of the dataset, with a mean follow-up of 1.85 years (AHC group) and 3.75 years (no AHC group), generated a rich source of information.
Given that severity of ID is sometimes associated with poorer health, it would have been helpful to adjust for severity of ID in the analysis as this may have accounted for some of the findings. However, over 65% of the medical records in both groups gave no clear indication of the severity of the people's ID, and we were therefore unable to adjust for severity of ID in our analysis.
An additional weakness of the study is that we have only included information on health care resource use and costs. Improved care as a result of AHCs may also have a positive impact on quality of life, morbidity and mortality. Morbidity changes may have been captured indirectly through unplanned health care attendances, but we had no information available on quality of life, and the sample size and follow-up was not sufficient to assess mortality. The wider potential benefits of AHC should examine these factors further as part of future research.
This analysis was heavily reliant on the accuracy of recording of resource use in Read codes, and there may be differences between staff in the quality of Read code recording. In particular, THIN database only captures secondary care services on the basis of letters sent from secondary care services to practices, and only a limited number of general practices are linked to the Hospital Episode Statistics. Recorded data and assumptions for non-available data were used to inform our assessments of outpatient visits and the length of inpatient care for any type of intervention detected in the medical records. As a result, there may be some missing data, because of either letters not sent to practices about secondary care access or letters not coded in Read codes. Therefore, we may have underestimated the costs associated with hospitalisation as well as the cost of outpatient appointments. We were also unable to comment on the quality or overall content of the entries recorded in people's medical files.
Although these data were collected from the period of 2008-2011 and may not reflect the current practice in health care provided for people with ID, it does serve as feasibility study upon which other studies could be modelled. In addition, as this is an observational study, the results could have been influenced by unobserved confounding factors contributing to the health care costs. Gathering data on patient services from government databases can also be a more efficient way to conduct economic evaluations of services than conducting full-scale randomised control trials (Franklin et al. 2017 ).
Conclusion
People with ID who did not have an AHC had a significant increase in unplanned health care use, which was not seen in people with AHCs. This suggests that AHCs may have led to more proactive management of health care for people with ID, although AHCs delivered in primary care for people with ID overall led to higher costs. Further research is needed to detect whether an AHC for people with ID translates into improved outcomes, reduced mortality and better quality of life, which may justify the additional cost. Also, our work showed that the analysis of THIN database is feasible and therefore could support a funding application to collect and use a larger sample.
